Physician profile
Thomas C Howard
NPI 1932369584
$1,365.69
in general payments reported to CMS, 2019-2025
13 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $91.83 · 2021: $104 · 2022: $212 · 2023: $331 · 2024: $175 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $691.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $501.71 | 2019-2025 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Abbvie INC. | $345.00 | 2023-2025 | |
| Allergan, INC. | $118.91 | 2021-2022 | |
| Tei Medical INC. | $85.36 | 2019 | |
| Depuy Synthes Sales INC. | $75.01 | 2019 | |
| Smith+Nephew, INC. | $49.87 | 2021-2025 | Stravix Pl |
| Kci USA, INC. | $45.01 | 2020 | |
| Sientra, INC. | $36.71 | 2019-2020 | |
| Integra Lifesciences Corporation | $33.16 | 2020-2021 | |
| Innovation Technologies INC | $27.90 | 2025 | Irrisept |
| Acell, INC. | $19.06 | 2019 | |
| Organogenesis INC. | $14.41 | 2020 | |
| Osiris Therapeutics INC. | $13.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.